Immunological Concerns with Bioengineering Approaches

DAVID M. HARLAN,a CHRISTOPHER L. KARP,b POLLY MATZINGER,c DAVID H. MUNN,d RICHARD M. RANSOHOFF,e AND DENNIS W. METZGERf aNational Institute of Diabetes, Digestive and Kidney Diseases, NIH, Bethesda, Maryland, USA bChildren’s Hospital Research Foundation, University of Cincinnati, Cincinnati, Ohio, USA cNational Institute of Arthritis and Immune Diseases, NIH, Bethesda, Maryland, USA dMedical College of Georgia, Augusta, Georgia, USA eLerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA fCenter for Immunology and Microbial Disease, Albany Medical College, Albany, New York, USA

[1]  H. Nomiyama,et al.  Chemokines in immunity. , 2001, Advances in immunology.

[2]  R. Medzhitov,et al.  Innate immune recognition: mechanisms and pathways , 2000, Immunological reviews.

[3]  J. Bluestone New perspectives of CD28-B7-mediated T cell costimulation. , 1995, Immunity.

[4]  R. Tsai,et al.  Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. , 2000, The New England journal of medicine.

[5]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[6]  D. Munn,et al.  Macrophage suppression of T cell activation: a potential mechanism of peripheral tolerance. , 1999, International reviews of immunology.

[7]  S. Badylak,et al.  Porcine small intestinal submucosa (SIS): a bioscaffold supporting in vitro primary human epidermal cell differentiation and synthesis of basement membrane proteins. , 2001, Burns : journal of the International Society for Burn Injuries.

[8]  M. Roncarolo,et al.  Differentiation of T Regulatory Cells by Immature Dendritic Cells , 2001, The Journal of experimental medicine.

[9]  Nina Bhardwaj,et al.  Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells , 2001, The Journal of experimental medicine.

[10]  A. Carpentier,et al.  Biochemical properties of heat-treated valvular bioprostheses. , 2001, The Annals of thoracic surgery.

[11]  S. Badylak,et al.  Enhanced bone regeneration using porcine small intestinal submucosa. , 1999, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[12]  D. Harlan,et al.  Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. , 1999, Diabetes.

[13]  Stephen F. Badylak,et al.  Galα(1,3)Gal Epitope in Porcine Small Intestinal Submucosa , 2000 .

[14]  S. Badylak,et al.  Galalpha(1,3)Gal epitope in porcine small intestinal submucosa. , 2000, Tissue engineering.

[15]  R. Locksley,et al.  The Instructive Role of Innate Immunity in the Acquired Immune Response , 1996, Science.

[16]  S. Bonner-Weir,et al.  In vitro cultivation of human islets from expanded ductal tissue. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Steinman,et al.  Dendritic cells in transplantation--friend or foe? , 2001, Immunity.

[18]  R. Ransohoff,et al.  Monocyte chemoattractant protein (MCP)-1 is rapidly expressed by sympathetic ganglion neurons following axonal injury , 2001, Neuroreport.

[19]  J. Bluestone New perspectives of C1328-137-mediated T cell costimulation , 1995 .

[20]  H. Kolb,et al.  Cutting Edge: Heat Shock Protein 60 Is a Putative Endogenous Ligand of the Toll-Like Receptor-4 Complex1 , 2000, The Journal of Immunology.

[21]  D. Munn,et al.  Prevention of T cell–driven complement activation and inflammation by tryptophan catabolism during pregnancy , 2001, Nature Immunology.

[22]  A. Aderem,et al.  Toll-like receptors in the induction of the innate immune response , 2000, Nature.

[23]  D. Munn,et al.  Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? , 1999, Immunology today.

[24]  S. Badylak,et al.  Small intestinal submucosa: a rapidly resorbed bioscaffold for augmentation cystoplasty in a dog model. , 1998, Tissue engineering.

[25]  J M Anderson,et al.  Directions for improvement of substitute heart valves: National Heart, Lung, and Blood Institute's Working Group report on heart valves. , 1997, Journal of biomedical materials research.

[26]  D. Harlan,et al.  Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates , 1999, Nature Medicine.

[27]  D. Wakefield,et al.  Regulation of T Lymphocyte Trafficking into Lymph Nodes During an Immune Response by the Chemokines Macrophage Inflammatory Protein (MIP)-1α and MIP-1β , 1998, The Journal of Immunology.

[28]  Carsten J. Kirschning,et al.  Endocytosed HSP60s Use Toll-like Receptor 2 (TLR2) and TLR4 to Activate the Toll/Interleukin-1 Receptor Signaling Pathway in Innate Immune Cells* , 2001, The Journal of Biological Chemistry.

[29]  D. Butler,et al.  In vitro characterization of mesenchymal stem cell-seeded collagen scaffolds for tendon repair: effects of initial seeding density on contraction kinetics. , 2000, Journal of biomedical materials research.

[30]  P. Matzinger Tolerance, danger, and the extended family. , 1994, Annual review of immunology.

[31]  U. Grohmann,et al.  CD40 Ligation Ablates the Tolerogenic Potential of Lymphoid Dendritic Cells1 , 2001, The Journal of Immunology.

[32]  D. Harlan,et al.  INDUCTION THERAPY WITH MONOCLONAL ANTIBODIES SPECIFIC FOR CD80 AND CD86 DELAYS THE ONSET OF ACUTE RENAL ALLOGRAFT REJECTION IN NON-HUMAN PRIMATES1 , 2001, Transplantation.

[33]  D. Harlan,et al.  The future of organ and tissue transplantation: can T-cell costimulatory pathway modifiers revolutionize the prevention of graft rejection? , 1999, JAMA.

[34]  D. Kioussis,et al.  "Infectious" transplantation tolerance , 1993, Science.

[35]  R. Ransohoff,et al.  Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. , 1996, Journal of immunology.

[36]  D. Munn,et al.  Inhibition of  T Cell Proliferation by Macrophage Tryptophan Catabolism , 1999, The Journal of experimental medicine.

[37]  D. Munn,et al.  Prevention of allogeneic fetal rejection by tryptophan catabolism. , 1998, Science.

[38]  G. Szot,et al.  Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation. , 1997, Journal of immunology.

[39]  D. Wakefield,et al.  Regulation of T lymphocyte trafficking into lymph nodes during an immune response by the chemokines macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta. , 1998, Journal of immunology.

[40]  Jerome F. Strauss,et al.  The Extra Domain A of Fibronectin Activates Toll-like Receptor 4* , 2001, The Journal of Biological Chemistry.

[41]  R. McKay,et al.  Differentiation of Embryonic Stem Cells to Insulin-Secreting Structures Similar to Pancreatic Islets , 2001, Science.

[42]  Ames,et al.  Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen , 2000 .

[43]  S. Badylak,et al.  XENOGENEIC EXTRACELLULAR MATRIX GRAFTS ELICIT A TH2-RESTRICTED IMMUNE RESPONSE1 , 2001, Transplantation.

[44]  P. Matzinger,et al.  An innate sense of danger. , 1998, Seminars in immunology.

[45]  D. Harlan,et al.  CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[46]  B. Stokes,et al.  Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury , 1998, Journal of neuroscience research.

[47]  D. Harlan,et al.  Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[48]  H. Waldmann,et al.  Dendritic cells and prospects for transplantation tolerance. , 2000, Current opinion in immunology.